NANJING PHARMACEUTICAL COMPANY LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 600713 for the last quarter is 13.01 B CNY, and it's 1.26% lower compared to the previous quarter. The net income of Q4 23 is 137.53 M CNY.